BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 25369469)

  • 1. AP2 suppresses osteoblast differentiation and mineralization through down-regulation of Frizzled-1.
    Yu S; Yerges-Armstrong LM; Chu Y; Zmuda JM; Zhang Y
    Biochem J; 2015 Feb; 465(3):395-404. PubMed ID: 25369469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional Regulation of Frizzled-1 in Human Osteoblasts by Sp1.
    Yu S; Yerges-Armstrong LM; Chu Y; Zmuda JM; Zhang Y
    PLoS One; 2016; 11(10):e0163277. PubMed ID: 27695039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F1 effects on osteoblast differentiation and mineralization are mediated through up-regulation of frizzled-1.
    Yu S; Yerges-Armstrong LM; Chu Y; Zmuda JM; Zhang Y
    Bone; 2013 Oct; 56(2):234-41. PubMed ID: 23806799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation.
    Thapa N; Kang KB; Kim IS
    Bone; 2005 Feb; 36(2):232-42. PubMed ID: 15780949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
    Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
    J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and association analysis of frizzled 1 (FZD1) promoter haplotypes with femoral neck geometry.
    Zhang Y; Kuipers AL; Yerges-Armstrong LM; Nestlerode CS; Jin Z; Wheeler VW; Patrick AL; Bunker CH; Zmuda JM
    Bone; 2010 Apr; 46(4):1131-7. PubMed ID: 20051274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin C affects mineralization of SaOS2 osteoblast-like cells through matrix vesicles.
    Li C; Cui Y; Luan J; Zhou X; Li H; Wang H; Shi L; Han J
    Drug Discov Ther; 2016; 10(2):82-7. PubMed ID: 26961327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SaOS2 Osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes.
    Prideaux M; Wijenayaka AR; Kumarasinghe DD; Ormsby RT; Evdokiou A; Findlay DM; Atkins GJ
    Calcif Tissue Int; 2014 Aug; 95(2):183-93. PubMed ID: 24916279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal.
    Byers BA; Pavlath GK; Murphy TJ; Karsenty G; García AJ
    J Bone Miner Res; 2002 Nov; 17(11):1931-44. PubMed ID: 12412799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
    Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
    J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential involvement of the interaction between insulin-like growth factor binding protein (IGFBP)-6 and LIM mineralization protein (LMP)-1 in regulating osteoblast differentiation.
    Strohbach C; Kleinman S; Linkhart T; Amaar Y; Chen ST; Mohan S; Strong D
    J Cell Biochem; 2008 Aug; 104(5):1890-905. PubMed ID: 18395833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
    Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
    Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.
    Gordon JA; Tye CE; Sampaio AV; Underhill TM; Hunter GK; Goldberg HA
    Bone; 2007 Sep; 41(3):462-73. PubMed ID: 17572166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.
    Lecanda F; Avioli LV; Cheng SL
    J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation.
    Choi YA; Lim J; Kim KM; Acharya B; Cho JY; Bae YC; Shin HI; Kim SY; Park EK
    J Proteome Res; 2010 Jun; 9(6):2946-56. PubMed ID: 20359165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone sialoprotein and its transcriptional regulatory mechanism.
    Ogata Y
    J Periodontal Res; 2008 Apr; 43(2):127-35. PubMed ID: 18302613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.